A detailed history of Carmichael Hill & Associates, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Carmichael Hill & Associates, Inc. holds 244 shares of BAX stock, worth $8,225. This represents 0.0% of its overall portfolio holdings.

Number of Shares
244
Previous 244 -0.0%
Holding current value
$8,225
Previous $8,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 30, 2020

BUY
$76.7 - $88.45 $18,714 - $21,581
244 New
244 $20,000
Q1 2019

Apr 23, 2019

SELL
$64.48 - $81.31 $338,133 - $426,389
-5,244 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$70.71 - $77.75 $370,803 - $407,721
5,244 New
5,244 $404,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Carmichael Hill & Associates, Inc. Portfolio

Follow Carmichael Hill & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.